Cargando…
Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?
There have been many exciting new breakthroughs in understanding tumour biology. This has opened up the possibility of personalized treatment for people with certain tumours. The epidermal growth factor receptor (EGFR) and K-ras are two such targets that can help classify tumours on a molecular basi...
Autores principales: | Mileshkin, Linda, Shah, Bhaumik, Michael, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359779/ https://www.ncbi.nlm.nih.gov/pubmed/22666589 http://dx.doi.org/10.1155/2012/838509 |
Ejemplares similares
-
Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside
por: Shad, Mujeeb U.
Publicado: (2021) -
What’s New in Cryptococcus gattii: From Bench to Bedside and Beyond
por: Beardsley, Justin, et al.
Publicado: (2022) -
Bench-to-bedside review: Metabolism and nutrition
por: Casaer, Michaël P, et al.
Publicado: (2008) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury: From Bench to Bedside
por: Hebert, Jessica F., et al.
Publicado: (2022)